[en] Murine double minute 2 and 4 (Mdm2, Mdm4) are major p53-negative regulators, preventing thus uncontrolled apoptosis induction in numerous cell types, although their function in the female germ line has received little attention. In the present work, we have generated mice with specific invalidation of Mdm2 and Mdm4 genes in the mouse oocyte (Mdm2(Ocko) and Mdm4(Ocko) mice), to test their implication in survival of these germ cells. Most of the Mdm2(Ocko) but not Mdm4(Ocko) mice were sterile, with a dramatic reduction of the weight of ovaries and genital tract, a strong increase in follicle-stimulating hormone and luteinizing hormone serum levels, and a reduction of anti-mullerian hormone serum levels. Histological analyses revealed an obvious decrease of the number of growing follicles beyond the primary stage in Mdm2(Ocko) ovaries in comparison to controls, with a pronounced increase in the apparition of primary atretic follicles, most being devoid of oocyte. Similar phenotypes were observed with Mdm2(Ocko) Mdm4(Ocko) ovaries, with no worsening of the phenotype. However, we failed to detect any increase in p53 level in mutant oocytes, nor any other apoptotic marker, introgression of this targeted invalidation in p53-/- mice restored the fertility of females. This study is the first to show that Mdm2, but not Mdm4, has a critical role in oocyte survival and would be involved in premature ovarian insufficiency phenotype.
Coulam CB, Adamson SC and Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67, 604–606.
Pedersen T and Peters H (1968) Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17, 555–557.
Kerr JB, Myers M and Anderson RA (2013) The dynamics of the primordial follicle reserve. Reproduction 146, R205–R215.
Livera G, Petre-Lazar B, Guerquin MJ, Trautmann E, Coffigny H and Habert R (2008) p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 135, 3–12.
Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z, Elvin JA, Bronson RT, Crum CP and McKeon F (2006) p63 protects the female germ line during meiotic arrest. Nature 444, 624–628.
Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, Mattei M, Candi E, De Felici M, Melino G et al. (2009) Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 15, 1179–1185.
Vandormael-Pournin S, Guigon CJ, Ishaq M, Coudouel N, Ave P, Huerre M, Magre S, Cohen-Tannoudji J and Cohen-Tannoudji M (2015) Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells. Cell Death Differ 22, 108–117.
Bolcun-Filas E, Rinaldi VD, White ME and Schimenti JC (2014) Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science 343, 533–536.
Hsueh AJ, Billig H and Tsafriri A (1994) Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15, 707–724.
Honda R, Tanaka H and Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25–27.
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323–331.
Prives C and Hall PA (1999) The p53 pathway. J Pathol 187, 112–126.
Lavin MF and Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13, 941–950.
Marine JC and Lozano G (2010) Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17, 93–102.
Jones SN, Roe AE, Donehower LA and Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206–208.
Montes de Oca Luna R, Wagner DS and Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378, 203–206.
de Vries WN, Binns LT, Fancher KS, Dean J, Moore R, Kemler R and Knowles BB (2000) Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26, 110–112.
Grier JD, Yan W and Lozano G (2002) Conditional allele of mdm2 which encodes a p53 inhibitor. Genesis 32, 145–147.
Grier JD, Xiong S, Elizondo-Fraire AC, Parant JM and Lozano G (2006) Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. Mol Cell Biol 26, 192–198.
Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4, 1–7.
Lecureuil C, Fontaine I, Crepieux P and Guillou F (2002) Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice. Genesis 33, 114–118.
Hanoux V, Pairault C, Bakalska M, Habert R and Livera G (2007) Caspase-2 involvement during ionizing radiation-induced oocyte death in the mouse ovary. Cell Death Differ 14, 671–681.
Fouchecourt S, Livera G, Messiaen S, Fumel B, Parent AS, Marine JC and Monget P (2016) Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility. Cell Death Differ 23, 521–530.
Beumer TL, Roepers-Gajadien HL, Gademan IS, van Buul PP, Gil-Gomez G, Rutgers DH and de Rooij DG (1998) The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ 5, 669–677.
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825.
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446.
Eskelinen EL (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 27, 495–502.
Williams SA and Stanley P (2011) Premature ovarian failure in mice with oocytes lacking core 1-derived O-glycans and complex N-glycans. Endocrinology 152, 1057–1066.
Chen Z, Kang X, Wang L, Dong H, Wang C, Xiong Z, Zhao W, Jia C, Lin J, Zhang W et al. (2015) Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure. J Biol Chem 290, 6387–6396.
Pitman JL, McNeilly AS, McNeilly JR, Hays LE, Bagby GC Jr, Sawyer HR and McNatty KP (2012) The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. Int J Dev Biol 56, 949–958.
Durlinger AL, Visser JA and Themmen AP (2002) Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124, 601–609.
Shen H and Maki CG (2011) Pharmacologic activation of p53 by small-molecule MDM2 antagonists. Curr Pharm Des 17, 560–568.
Zhang B, Golding BT and Hardcastle IR (2015) Small-molecule MDM2-p53 inhibitors: recent advances. Future Med Chem 7, 631–645.